BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37137487)

  • 1. ANP32B suppresses B-cell acute lymphoblastic leukemia through activation of PU.1 in mice.
    Yang Q; Liu HR; Yang S; Wei YS; Zhu XN; Zhi Z; Zhu D; Chen GQ; Yu Y
    Cancer Sci; 2023 Jul; 114(7):2882-2894. PubMed ID: 37137487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells.
    Yang S; Zhu XN; Zhang HL; Yang Q; Wei YS; Zhu D; Liu MD; Shen SM; Xia L; He P; Ge MK; Pan YL; Zhao M; Wu YL; Zheng JK; Chen GQ; Yu Y
    Blood; 2021 Dec; 138(24):2485-2498. PubMed ID: 34359074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development.
    Reilly PT; Afzal S; Gorrini C; Lui K; Bukhman YV; Wakeham A; Haight J; Ling TW; Cheung CC; Elia AJ; Turner PV; Mak TW
    Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10243-8. PubMed ID: 21636789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylation.
    Yang S; Zhou L; Reilly PT; Shen SM; He P; Zhu XN; Li CX; Wang LS; Mak TW; Chen GQ; Yu Y
    Cell Death Dis; 2016 Feb; 7(2):e2082. PubMed ID: 26844697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylation.
    Wan X; Wang J; Fang F; Hu Y; Zhang Z; Tao Y; Zhang Y; Yu J; Wu Y; Zhou B; Yin H; Ma L; Li X; Zhuo R; Cheng W; Zhang S; Pan J; Lu J; Hu S
    Cancer Cell Int; 2024 Feb; 24(1):81. PubMed ID: 38383388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis.
    Li CX; Shen SM; Wang LS; Yu Y
    Mol Med Rep; 2015 Apr; 11(4):2813-8. PubMed ID: 25483709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells.
    Shen SM; Yu Y; Wu YL; Cheng JK; Wang LS; Chen GQ
    Carcinogenesis; 2010 Mar; 31(3):419-26. PubMed ID: 20015864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS; Greene JM; McConnell TS; Willman CL
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes.
    Ma L; Wang J; Zhang Y; Fang F; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Sang X; Zhang K; Lu L; Wan X; Chen Y; Yu J; Zhuo R; Wu S; Lu J; Pan J; Hu S
    Cancer Biol Ther; 2022 Dec; 23(1):1-15. PubMed ID: 36170346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fyn is not essential for Bcr-Abl-induced leukemogenesis in mouse bone marrow transplantation models.
    Doki N; Kitaura J; Uchida T; Inoue D; Kagiyama Y; Togami K; Isobe M; Ito S; Maehara A; Izawa K; Kato N; Oki T; Harada Y; Nakahara F; Harada H; Kitamura T
    Int J Hematol; 2012 Feb; 95(2):167-75. PubMed ID: 22189847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) contributes to retinoic acid-induced differentiation of leukemic cells.
    Yu Y; Shen SM; Zhang FF; Wu ZX; Han B; Wang LS
    Biochem Biophys Res Commun; 2012 Jul; 423(4):721-5. PubMed ID: 22705300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANP32 Proteins Are Essential for Influenza Virus Replication in Human Cells.
    Staller E; Sheppard CM; Neasham PJ; Mistry B; Peacock TP; Goldhill DH; Long JS; Barclay WS
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells.
    Waldron T; De Dominici M; Soliera AR; Audia A; Iacobucci I; Lonetti A; Martinelli G; Zhang Y; Martinez R; Hyslop T; Bender TP; Calabretta B
    Leukemia; 2012 Apr; 26(4):644-53. PubMed ID: 21960247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival.
    Chang KH; Sanchez-Aguilera A; Shen S; Sengupta A; Madhu MN; Ficker AM; Dunn SK; Kuenzi AM; Arnett JL; Santho RA; Agirre X; Perentesis JP; Deininger MW; Zheng Y; Bustelo XR; Williams DA; Cancelas JA
    Blood; 2012 Jul; 120(4):800-11. PubMed ID: 22692505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANP32B Deficiency Protects Mice From Lethal Influenza A Virus Challenge by Dampening the Host Immune Response.
    Beck S; Zickler M; Pinho Dos Reis V; Günther T; Grundhoff A; Reilly PT; Mak TW; Stanelle-Bertram S; Gabriel G
    Front Immunol; 2020; 11():450. PubMed ID: 32231671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
    Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice.
    Chemnitz J; Pieper D; Stich L; Schumacher U; Balabanov S; Spohn M; Grundhoff A; Steinkasserer A; Hauber J; Zinser E
    Sci Rep; 2019 Mar; 9(1):4853. PubMed ID: 30890743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
    Williams RT; Sherr CJ
    Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase.
    Roumiantsev S; de Aos IE; Varticovski L; Ilaria RL; Van Etten RA
    Blood; 2001 Jan; 97(1):4-13. PubMed ID: 11133737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.
    Gleissner B; Gökbuget N; Bartram CR; Janssen B; Rieder H; Janssen JW; Fonatsch C; Heyll A; Voliotis D; Beck J; Lipp T; Munzert G; Maurer J; Hoelzer D; Thiel E;
    Blood; 2002 Mar; 99(5):1536-43. PubMed ID: 11861265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.